Real-time enrollment status for this advanced egfr positive solid tumor clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 11:43 AM UTC
| NCT Number | NCT04412616 |
| Recruiting Status | Recruiting |
| Condition | Advanced EGFR Positive Solid Tumor |
| Phase | PHASE1 |
| Target Enrollment | 60 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Changchun Intellicrown Pharmaceutical Co. LTD |
| Last Updated on CT.gov | June 10, 2025 (Jun 10, 2025) |
As of July 18, 2026: Clinical trial NCT04412616 is currently recruiting participants. This phase1 study for advanced egfr positive solid tumor is actively seeking new participants at 3 locations across the United States. The study is sponsored by Changchun Intellicrown Pharmaceutical Co. LTD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04412616 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04412616 was last updated Jun 10, 2025 (June 10, 2025). HelloStudys verifies this status automatically.